“At the moment, mice and ferrets have already been immunized and research on lower primates is beginning,” TASS quoted him as saying.
Maksyutov added that it is planned to complete animal studies in a laboratory format at the end of April and after that go to the preclinical research stage.
“And the next stage of clinical research is already directly in humans, in June, human trials will begin,” he said.
On the basis of six technological platforms, 26 different vaccine variants are being developed, the director of “Vector” added. They will be investigated during laboratory tests. The best options will be given for preclinical studies, and after that with the permission of the Ministry of Health for clinical studies in humans.
Earlier it became known that the Ministry of Health of Russia will begin clinical trials of a vaccine against coronavirus infection in five to six months.
The representative of WHO in Russia, Melita Vujnovich, in turn, said that the vaccine against coronavirus would appear no earlier than in a year.